UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 10-Q
Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
For the Quarter Ended January 31, 1998 Commission File Number 0-19019
---------------- -------
PRIMEDEX HEALTH SYSTEMS, INC.
(Exact name of registrant as specified in charter)
New York 13-3326724
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
1516 Cotner Avenue
Los Angeles, California 90025
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (310) 478-7808
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 of 15(d) of the Securities and Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes X No ___
Number of shares outstanding of the issuer's common stock as of May 7, 1998 was
39,132,260 [excluding treasury shares].
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC.
PART I - FINANCIAL INFORMATION
The condensed consolidated financial statements included herein have been
prepared by the Registrant without audit, pursuant to the rules and regulations
of the Securities and Exchange Commission. Certain information and footnote
disclosures normally included in financial statements prepared in accordance
with generally accepted accounting principles have been condensed or omitted
pursuant to such rules and regulations. However, the Registrant believes that
the disclosures are adequate to make the information presented not misleading.
It is suggested that these consolidated financial statements be read in
conjunction with the financial statements and the notes thereto included in the
Registrant's latest Annual Report on Form 10-K.
In the opinion of the Registrant, all adjustments, consisting of normal
recurring adjustments, necessary to present fairly the financial position of the
Registrant as of January 31, 1998, and the results of its operations and changes
in its cash flows for the three months ended January 31, 1998 and 1997, have
been made. The results of operations for such interim periods are not
necessarily indicative of the results to be expected for the entire year.
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
- ------------------------------------------------------------------------------
CONSOLIDATED BALANCE SHEETS
- ------------------------------------------------------------------------------
January 31, October 31,
1 9 9 8 1 9 9 7
[Unaudited]
Assets:
Current Assets:
Cash and Cash Equivalents $ 465,735 $ 129,517
Marketable Securities - Held for Sale 1,431,563 --
Accounts Receivable - Net 17,082,607 16,933,340
Unbilled Receivables 476,510 693,847
Other Receivables - Current 1,314,690 2,390,755
Due from Related Party 105,000 55,568
Other 905,955 765,467
---------- -----------
Total Current Assets 21,782,060 20,968,494
---------- -----------
Property, Plant and Equipment - Net 32,200,444 33,401,161
---------- -----------
Other Assets:
Accounts Receivable - Net 6,148,173 5,810,814
Due from Related Parties 967,246 897,133
Other Receivables -- 899,896
Goodwill - Net 19,513,587 20,168,729
Other 3,121,584 4,193,696
---------- -----------
Total Other Assets 29,750,590 31,970,268
---------- -----------
Total Assets $83,733,094 $86,339,923
=========== ===========
See Notes to Consolidated Financial Statements.
1
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
- ------------------------------------------------------------------------------
CONSOLIDATED BALANCE SHEETS
- ------------------------------------------------------------------------------
January 31, October 31,
1 9 9 8 1 9 9 7
[Unaudited]
Liabilities and Stockholders' Deficit:
Current Liabilities:
Cash Overdraft $ 901,400 $ 319,481
Accounts Payable 3,463,463 4,010,861
Accrued Expenses - Current 4,925,953 5,270,787
Accrued Expenses - Professional Fees - Current 1,744,614 1,596,916
Notes and Leases Payable - Current 24,210,499 20,341,372
Accrued Restructuring Costs 248,396 1,062,026
Deferred Revenue - Covenant Not-to-Compete -
Current 200,000 200,000
Other 167,717 194,084
---------- -----------
Total Current Liabilities 35,862,042 32,995,527
---------- -----------
Long-Term Liabilities:
Subordinated Debentures Payable 21,367,000 22,923,000
Notes and Leases Payable 50,554,803 51,445,256
Deferred Revenue - Covenant Not-to-Compete 1,616,666 1,666,666
Accrued Expenses 255,323 225,292
Accrued Expenses - Professional Fees 652,155 582,998
---------- -----------
Total Long-Term Liabilities 74,445,947 76,843,212
---------- -----------
Commitments and Contingencies -- --
---------- -----------
Minority Interest 761,664 1,430,788
---------- -----------
Stockholders' Deficit:
Common Stock - $.01 Par Value, 100,000,000
Shares Authorized; 40,757,260 and 40,432,260
Shares Issued; 39,132,260 and 38,807,260
Shares Outstanding at January 31, 1998 and
October 31, 1997, Respectively 407,572 404,322
Paid-in Capital 99,491,650 99,434,150
Retained Earnings [Deficit] (126,590,834) (124,153,129)
Stock Subscription - Related Party (30,000) --
---------- -----------
Totals (26,721,612) (24,314,657)
Less: Treasury Stock - 1,625,000 Shares, At Cost (614,947) (614,947)
---------- -----------
Total Stockholders' Deficit (27,336,559) (24,929,604)
----------- -----------
Total Liabilities and Stockholders' Deficit $ 83,733,094 $86,339,923
=========== ===========
See Notes to Consolidated Financial Statements.
2
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
- ------------------------------------------------------------------------------
CONSOLIDATED STATEMENTS OF OPERATIONS [UNAUDITED]
- ------------------------------------------------------------------------------
Three months ended
January 31,
1 9 9 8 1 9 9 7
------- -------
Revenue:
Revenue $30,366,063 $31,838,043
Less: Allowances 16,101,127 14,200,921
---------- -----------
Net Revenue 14,264,936 17,637,122
---------- -----------
Operating Expenses:
Operating Expenses 12,169,602 14,927,388
Depreciation and Amortization 2,117,207 2,377,779
Provision for Bad Debts 485,696 572,542
Impairment Loss of Long-Lived Assets -- 4,953,783
---------- -----------
Total Operating Expenses 14,772,505 22,831,492
---------- -----------
Loss from Operations (507,569) (5,194,370)
---------- -----------
Other [Expenses] and Revenue:
Interest Expense (2,226,597) (2,660,008)
Interest Income 105,470 53,056
Gain on Sale of Subsidiaries and Divisions 335,899 --
Other Income 132,425 134,933
---------- -----------
Total Other Expenses (1,652,803) (2,472,019)
---------- -----------
Loss Before Minority Interest in Income
of Subsidiaries, Cumulative Effect of Change
in Accounting Principle and Extraordinary Item (2,160,372) (7,666,389)
Minority Interest in Income of Subsidiaries (87,161) (142,491)
---------- -----------
Loss Before Cumulative Effect of Change in
Accounting Principle and Extraordinary Item (2,247,533) (7,808,880)
Cumulative Effect of Change in Accounting Principle (779,294) --
---------- -----------
Loss Before Extraordinary Item (3,026,827) (7,808,880)
Extraordinary Item - Gain from Early Extinguishment
of Debt [Net of Income Taxes of $-0- for the
Three Months Ended January 31, 1998 and 1997,
Respectively] 589,122 --
---------- -----------
Net [Loss] $(2,437,705) $(7,808,880)
=========== ===========
[Loss] Per Share:
Loss Before Change in Accounting Principle and
Extraordinary Item $ (.06) $ (.20)
Change in Accounting Principle - Write-off of Costs
of Start-up Activities (.02) --
Extraordinary Item .02 --
---------- -----------
Net Loss Per Share $ (.06) $ (.20)
========== ===========
Weighted Average Shares Outstanding 38,859,458 38,932,260
========== ===========
See Notes to Consolidated Financial Statements.
3
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
- ------------------------------------------------------------------------------
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
- ------------------------------------------------------------------------------
<TABLE>
Common Stock Retained Stock Total
Number Par Value Treasury Paid-in Earnings Subscription Stockholders'
of Shares Amount Stock Capital [Deficit] Related Party [Deficit]
<S> <C> <C> <C> <C> <C> <C> <C>
Balance - November 1, 1997 40,432,260 $404,322 $(614,947) $99,434,150 $(124,153,129)$ -- $(24,929,604)
Issuance of Common Stock 325,000 3,250 -- 57,500 -- -- 60,750
Common Stock Subscribed -- -- -- -- -- (30,000) (30,000)
Net Loss for the three months
ended January 31, 1998 -- -- -- -- (2,437,705) -- (2,437,705)
---------- -------- --------- ---------- ------------- ----------- -----------
Balance - January 31, 1998
[Unaudited] 40,757,260 $407,572 $(614,947) $99,491,650 $(126,590,834)$ (30,000)$(27,336,559)
========== ======== ========= =========== ============= =========== ============
</TABLE>
See Notes to Consolidated Financial Statements.
4
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
- ------------------------------------------------------------------------------
CONSOLIDATED STATEMENTS OF CASH FLOWS [UNAUDITED]
- ------------------------------------------------------------------------------
<TABLE>
Three months ended
January 31,
1 9 9 8 1 9 9 7
------- -------
<S> <C> <C>
Cash [Used for] Provided by Continuing Operations $ (387,578) $ 1,467,992
Cash Used for Discontinued Operations -- (13,011)
---------- -----------
Net Cash - Operating Activities (387,578) 1,454,981
---------- -----------
Investing Activities:
Acquisitions - Net of Cash Acquired (487,945) (66,936)
Purchase of Property and Equipment (737,339) (384,191)
Proceeds - Sale of Centers or Equipment 20,000 --
Loans to Related Parties (75,000) --
---------- -----------
Net Cash - Investing Activities (1,280,284) (451,127)
---------- -----------
Financing Activities:
Cash Overdraft 581,919 614,121
Principal Payments on Capital Leases and Notes Payable (2,513,024) (1,816,317)
Proceeds from Short-Term Borrowings on Notes Payable 4,949,685 620,661
Joint Venture Distributions -- (228,125)
Joint Venture Proceeds 75,000 --
Repurchase of Bond Debentures (1,095,250) (170,049)
Issuance of Common Stock 5,750 --
---------- -----------
Net Cash - Financing Activities 2,004,080 (979,709)
---------- -----------
Net Increase in Cash and Cash Equivalents 336,218 24,145
Cash and Cash Equivalents - Beginning of Periods 129,517 151,870
---------- -----------
Cash and Cash Equivalents - End of Periods $ 465,735 $ 176,015
========== ==========
Supplemental Disclosures of Cash Flow Information:
Cash paid during the periods for:
Interest $2,200,195 $ 3,094,802
Income Taxes $ -- $ --
</TABLE>
See Notes to Consolidated Financial Statements.
5
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
- ------------------------------------------------------------------------------
CONSOLIDATED STATEMENTS OF CASH FLOWS [UNAUDITED]
- ------------------------------------------------------------------------------
Supplemental Schedule of Non-Cash Investing and Financing Activities:
The Company entered into capital leases or financed equipment through notes
payable for approximately $1,650,000 and $1,695,000 for the three months ended
January 31, 1998 and 1997, respectively.
During the three months ended January 31, 1998, the Company wrote-off
approximately $1,565,000 in net property and equipment, approximately $285,000
in net accounts receivable, approximately $735,000 in net goodwill,
approximately $19,000 in non current assets, approximately $865,000 in notes and
capital lease obligations, approximately $160,000 in other current liabilities
and approximately $398,000 in minority interest related to the sale of Scripps
Chula Vista to DHS effective January 1, 1998. As consideration, the Company
received 127,250 shares of DHS common stock valued at $11.25 per share as of the
transaction date.
During the three months ended January 31, 1998, the Company dissolved its
partnership between La Habra Imaging Group II and Friendly Hills Healthcare
Network, Inc. ["Friendly Hills"] effective December 31, 1997. Upon the
dissolution, the Company wrote-off approximately $270,000 of Friendly Hills
accounts receivable, approximately $365,000 in net property, approximately
$130,000 of accrued expenses and approximately $435,000 in minority interest.
The Company recorded a short-term receivable of approximately $95,000 as part of
the final dissolution.
During the three months ended January 31, 1997, the Company wrote-off
approximately $1,515,000 in net property and equipment, approximately $2,875,000
in net goodwill and $782,273 in deferred compensation related to the closure of
Parkside.
During the three months ended January 31, 1998, the Company issued 300,000
shares of its common stock and recorded $55,000 as due from related parties.
During the three months ended January 31, 1998, the Company received medical
equipment of approximately $352,000 in lieu of cash rebates for Fuji medical
film purchases.
See Notes to Consolidated Financial Statements.
6
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS [UNAUDITED]
- ------------------------------------------------------------------------------
[1] Summary of Significant Accounting Policies
Significant accounting policies of Primedex Health Systems, Inc. and affiliates
are set forth in the Company's Form 10-K for the year ended October 31, 1997 as
filed with the Securities and Exchange Commission.
During the three months ended January 31, 1998, the Company adopted the
Accounting Standards Executive Committee's ["AcSEC"] Statement of Position
["SOP"] No. 98-5, "Reporting on the Costs of Start-up Activities." As a result
of this decision, in January 1998, the Company reduced historical net
organizational costs and capitalized fees by approximately $780,000.
[2] Basis of Presentation
The accompanying interim consolidated financial statements are unaudited and
have been prepared in accordance with generally accepted accounting principles
and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and,
therefore, do not include all information and footnotes necessary for a fair
presentation of financial position, results of operations and cash flows in
conformity with generally accepted accounting principles for complete financial
statements; however, in the opinion of the management of the Company, all
adjustments consisting of normal recurring adjustments necessary for a fair
presentation of financial position, results of operations and cash flows for the
interim periods ended January 31, 1998 and 1997 have been made. The results of
operations for any interim period are not necessarily indicative of the results
for the full year. These interim consolidated financial statements should be
read in conjunction with the consolidated financial statements and notes thereto
contained in the Registrant's annual report on Form 10-K for the fiscal year
ended October 31, 1997.
[3] Goodwill
The Company's goodwill as of January 31, 1998 is shown net of accumulated
amortization of approximately $3,430,000. Amortization expense for the three
months ended January 31, 1998 and 1997 was approximately $320,000 and $420,000,
respectively. The 1998 decrease in amortization expense was primarily due to the
write-off of goodwill associated with the sales of DIS's Ultrasound Division and
four of its hospital-based MRI facilities to Diagnostic Health Services, Inc.
effective March 1, 1997.
During the three months ended January 31, 1998, the Company wrote-off
approximately $778,000 of DIS acquisition goodwill and approximately $43,000 of
related accumulated amortization with the sale of Scripps Chula Vista. In
addition, the Company wrote-off approximately $92,000 of Woodward Park
acquisition goodwill and approximately $4,000 of related accumulated
amortization. At the time of the acquisition, unrealized liabilities [written
off in January 1998] were recorded creating the goodwill.
The Company amortizes goodwill over the lesser of 20 years or the estimated
useful life of the assets.
[4] Due to/from Related Party
The Company has a $1,000,000 loan receivable due from its President and C.E.O.
in February 1999 discounted at 8%. For the three months ended January 31, 1998,
the Company recorded interest income on the note of approximately $20,000.
As of October 31, 1997, the Company advanced $30,000 to an officer of the
Company, at no interest, which will be repaid within the 1998 fiscal year.
During the three months ended January 31, 1998, the Company advanced an
additional $25,000 to the officer with the same terms.
7
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS [UNAUDITED], Sheet #2
- ------------------------------------------------------------------------------
[4] Due to/from Related Party [Continued]
As of October 31, 1997, the Company loaned an officer of the Company $25,000,
with interest at 6%. During the three months ended January 31, 1998, the Company
loaned an additional $105,000 to this officer prior to his contract
renegotiation and termination. In February 1998, the officer used his net
severance to repay $50,000 of the prior loans made to him by the Company. In
addition, as part of his contract renegotiation, the officer was loaned an
additional $75,000. The remaining $155,000 of loans due to the Company are to be
repaid in five years with interest at 6.5%. As part of the contract
renegotiation, the individual was retained as a legal consultant to the Company
to be paid $50,000 per year for five years.
[5] Litigation
The Company is a defendant in a class action pending in the United States
District Court for the District of New Jersey entitled "In re Hibbard Brown &
Company Securities Litigation" [No. 93 CV 1150]. The Company entered into a
preliminary settlement with the plaintiff class in the lawsuit by the payment of
$240,000 in April 1996. Although the settlement between the Company and the
plaintiff class was granted preliminary court approval, the settlement is
subject to final approval by the class and to final court approval which has not
yet been obtained. Management expects there will be no additional costs to
settle the case beyond the $240,000. The lawsuit continues with respect to the
other defendants. The Company remains convinced that it has not engaged in any
inappropriate conduct in this matter.
The Company is currently a party to other litigation, none of which is deemed
material by nature.
[6] Acquisitions, Sales and Divestitures
In February 1998, the Company dissolved its partnership between La Habra Imaging
Group II and Friendly Hills Healthcare Network, Inc. ["Friendly Hills"]
effective December 31, 1997. Upon the dissolution, the Company wrote-off
approximately $270,000 of Friendly Hills accounts receivable, approximately
$365,000 in net property, approximately $130,000 of accrued expenses and
approximately $435,000 in minority interest. The Company recorded a short-term
receivable of approximately $95,000 as part of the final dissolution. The
Company recognized a gain of approximately $23,000 on the dissolution and
continues to operate the now wholly-owned La Habra center. As part of the
dissolution, Friendly Hills acquired the modular building utilized by the
center. The Company entered into a five-year lease with Friendly Hills with an
initial base rent of $3,034 per month.
In March 1998, effective January 1, 1998, the Company's DIS subsidiary sold its
share of Scripps Chula Vista MRI L.P. ["SCV"] to Diagnostic Health Services,
Inc. ["DHS"] for 127,250 shares of DHS stock. As of the transaction date, the
shares were valued at $1,431,563 and recorded as marketable securities held for
sale [see Note 8]. Due to the sale, the Company wrote-off approximately $735,000
of net acquisition goodwill.
[7] Capital Transactions
During the three months ended January 31, 1998, the Company purchased an
additional 428,000 shares of DIS common stock for approximately $488,000.
Subsequent to the quarter's end, as of May 7, 1998, the Company has purchased an
additional 200,000 shares of DIS common stock for approximately $212,000
increasing its total ownership to 8,627,970 shares, or approximately 75%.
8
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS [UNAUDITED], Sheet #3
- ------------------------------------------------------------------------------
[7] Capital Transactions [Continued]
During the three months ended January 31, 1998, the Company repurchased
1,556,000 of its subordinated bond debentures for cash of approximately
$1,095,000. These bonds were retired and resulted in a gain on early
extinguishment of debt of approximately $461,000. Subsequent to the quarter's
end, as of May 7, 1998, the Company repurchased an additional 633,000 of its
subordinated bond debentures for approximately $380,000. When the bonds are
retired, the Company will recognize an additional gain from early extinguishment
of debt of approximately $253,000 while reducing quarterly interest payments to
approximately $518,000.
On December 4, 1997, a former employee of the Company exercised his options for
25,000 shares of the Company's common stock for $.23 per share, or $5,750.
During the three months ended January 31, 1998, a former officer of the Company,
who had existing options for 200,000 shares of the Company's common stock, was
granted options for an additional 100,000 shares as part of his contract buyout
and renegotiation. On January 20, 1998, the former officer exercised all of his
options for 300,000 shares of the Company's common stock for approximately $.183
per share, or $55,000. The former officer was loaned the entire $55,000 of which
$25,000 was repaid in February 1998 with the remainder to be repaid in five
years at 6.5% interest. In addition, the Company entered into an agreement with
the former officer whereby the Company agreed to purchase from him up to 600,000
shares of the Company's common stock owned by him at a price of $.40 per share,
in minimum increments of 100,000 shares, upon his election anytime subsequent to
December 31, 1998 and prior to February 28, 2003.
[8] Subsequent Events
In May 1998, the Company exercised its option to receive the $1.5 million in
post-closing payments related to the sale of DIS's MRI facilities to DHS in the
form of common stock of DHS. The Company received 200,000 shares of DHS stock
and sold the shares for $1,849,936 on May 8, 1998. The transaction will result
in a gain of approximately $534,000.
On May 15, 1998, the Company sold the 127,250 DHS shares it received from the
sale of SCV for approximately $1,230,000. The transaction will result in a loss
of approximately $200,000.
. . . . . . . . . . .
9
<PAGE>
Item 2:
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
- ------------------------------------------------------------------------------
Background
Primedex Health Systems, Inc. ["PHS"] was incorporated on October 21, 1985.
On November 1, 1990, the Company acquired a 51% interest in Viromedics, Inc.
["VMI"] for $700,000. On February 18, 1992, Future Medical Products ["FMP"], the
parent corporation of VMI, exercised its right to repurchase one-half of the VMI
stock from PHS at a price of $700,000. The Company owns approximately 19% of
VMI's outstanding capital stock as of January 31, 1998, which is accounted for
using the cost method at $-0-.
On April 30, 1992, the Company entered into a purchase agreement with Radnet
Management, Inc. and certain related companies ["Radnet"] for approximately
$66,000,000. The statement of operations and cash flows for the three months
ended January 31, 1998 and 1997 include the operations and cash transactions of
Radnet.
In November of 1995, the Company formed Radnet Managed Imaging Services, Inc.
["RMIS"], which acquired most of the assets of Future Diagnostics, Inc. ["FDI"|
by purchasing 100% of its outstanding stock for approximately $3.2 million
consisting of notes and assumed liabilities. The statement of operations and
cash flows for the three months ended January 31, 1997 reflect the operations
and cash transactions of FDI. Effective September 3, 1997, 100% of the
outstanding capital stock of FDI was sold to an unrelated party for
approximately $13,500,000 in cash, notes and assumed liabilities. The Company
continues to operate RMIS which provides utilization review services. The
statements of operations and cash flows for the three months ended January 31,
1998 and 1997 reflect the overhead costs and cash transactions of RMIS.
In March of 1996, the Company purchased 3,478,261 shares, or approximately 31%,
of Diagnostic Imaging Services, Inc. ["DIS"] for $4,000,000 with a five-year
warrant to acquire an additional 1,521,739 shares of DIS stock at $1.60 per
share. The $4 million was borrowed by the Company from a primary lending source.
During the four-month period ended July 31, 1996, the investment yielded a loss
to the Company of $313,649. Effective August 1, 1996, the Company issued a
five-year promissory note for $3,272,046 and five-year warrants to purchase
approximately 4,000,000 shares of PHS common stock at $.60 per share, to acquire
an additional 3,228,046 shares of DIS common stock. The purchase made PHS the
primary shareholder in DIS with approximately 59% ownership.
In subsequent purchases through May 7, 1998, the Company acquired an additional
1,921,663 shares of DIS stock from various related and unrelated parties for
approximately $2,340,000 increasing its ownership in DIS to approximately 75%.
The statements of operations and cash flows for the three months ended January
31, 1998 and 1997 reflect the operations and cash transactions with DIS.
Effective March 1, 1997, the Company sold the assets and related liabilities of
four of DIS's hospital-based MRI facilities and its ultrasound division to
Diagnostic Health Services, Inc. ["DHS"] for $15,972,720 in cash including
$2,000,000 in ten-year covenants not-to-compete. The covenants not-to-compete
were split equally between PHS and DIS and are classified as "Deferred Revenue"
on the Company's financial statements. The Company recognized a gain on the sale
of approximately $5,600,000 which included the write-off of approximately
$2,660,000 of net acquisition goodwill. In addition, a discounted receivable of
approximately $1,190,000 utilizing a 11.75% interest rate was recorded on the
Company's books for post-closing payments of $500,000 each to be made by DHS to
DIS on the first, second and third anniversaries of the closing date. The
Company had an option to receive these payments in the form of DHS common stock
valued at the mean average of the reported closing price of such common stock as
reported on the NASDAQ National Market for the five consecutive trading days
ending on the third day immediately prior to the closing date ["the Agreed
Value"] [See Note 8].
10
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
- ------------------------------------------------------------------------------
Background [Continued]
As a result of a continuing deteriorating business climate and other business
reasons at DIS's Santa Monica ["Parkside"] facility, on June 25, 1997, the
Company decided to close substantially all of its operations at the facility on
or about August 29, 1997. Due to this decision, the Company recognized an
impairment loss of approximately $4,550,000 which included the write-off of
approximately $1,530,000 of net acquisition goodwill. In May 1997, the Company
sold the facility's MRI for $65,000 to an unrelated party; in August 1997, the
Company's remaining Parkside assets were sold for approximately $400,000 to
another party who also assumed the centers building lease. The Company still
operates a separate entity, Parkside Radiology Women's Center ["Parkside
Womens"], which provides ultrasound, mammography, stereotactic breast biopsy and
bone densitometry services.
Effective January 1, 1997, the Company's DIS subsidiary opened its Scripps Chula
Vista MRI, L.P. ["SCV"] servicing patients in San Diego. The Company and Scripps
Health are equal partners with the Company serving as managing partner.
In March 1998, effective January 1, 1998, the Company's DIS subsidiary sold its
share of SCV to Diagnostic Health Services, Inc. ["DHS"] for 127,250 shares of
DHS stock. As of the transaction date, the shares were valued at $1,431,563 and
recorded as marketable securities held for sale [see Note 8]. Due to the sale,
the Company wrote-off approximately $735,000 of net acquisition goodwill.
Effective March 1, 1997, the Company acquired the assets and related liabilities
of Woodward Park Imaging Center ["WWP"] in Fresno for approximately $200,000 in
notes payable and assumed liabilities resulting in goodwill of approximately
$90,000. In January 1998, the goodwill was written-off due to the reversal of an
unrealized liability [See Note 3]. WWP is a full service, multi-modality imaging
center providing MRI, CT, mammography, ultrasound and general diagnostic
radiology services.
During the year ended October 31, 1997, the Company acquired the assets of Las
Posas Medical Imaging for $35,000 in cash and relocated DIS's Camarillo facility
to its location. No goodwill was recorded in this transaction.
In February 1998, the Company dissolved its partnership between La Habra Imaging
Group II and Friendly Hills Healthcare Network, Inc. ["Friendly Hills"]
effective December 31, 1997. Upon the dissolution, the Company wrote-off
approximately $270,000 of Friendly Hills accounts receivable, approximately
$365,000 in net property, approximately $130,000 of accrued expenses and
approximately $435,000 in minority interest. The Company recorded a short-term
receivable of approximately $95,000 as part of the final dissolution. The
Company recognized a gain of approximately $23,000 on the dissolution and
continues to operate the now wholly-owned La Habra center. As part of the
dissolution, Friendly Hills acquired the modular building utilized by the
center. The Company entered into a five-year building lease with Friendly Hills
with an initial base rent of $3,034 per month.
11
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
- ------------------------------------------------------------------------------
Forward-Looking Information
The forward-looking statements herein are based on current expectations that
involve a number of risks and uncertainties. Such forward-looking statements are
based on assumptions that the Company will have adequate financial resources to
fund the development and operation of its business, and there will be no
material adverse change in the Company's operations or business. The foregoing
assumptions are based on judgment with respect to, among other things,
information available to the Company, future economic, competitive and market
conditions and future business decisions, all of which are difficult or
impossible to predict accurately and many of which are beyond the Company's
control. Accordingly, although the Company believes that the assumptions
underlying the forward-looking statements are reasonable, any such assumption
could prove to be inaccurate and therefore there can be no assurance that the
results contemplated in forward-looking statements will be realized. There are a
number of other risks presented by the Company's business and operations which
could cause the Company's financial performance to vary markedly from prior
results or results contemplated by the forward-looking statements. Management
decisions, including budgeting, are subjective in many respects and periodic
revisions must be made to reflect actual conditions and business developments,
the impact of which may cause the Company to alter its capital investment and
other expenditures, which may also adversely affect the Company's results of
operations. In light of significant uncertainties inherent in forward-looking
information included in this Quarterly Report on Form 10-Q, the inclusion of
such information should not be regarded as a representation by the Company or
any other person that the Company's objectives or plans will be achieved.
The following discussion relates to the continuing activities of Primedex Health
Systems, Inc. and affiliates.
Results of Operations
The discussion of the results of continuing operations includes Radnet, PHS,
RMIS and DIS for the three months ended January 31, 1998. The discussion of the
results of continuing operations includes Radnet, PHS, RMIS, FDI and DIS for the
three months ended January 31, 1997. RMIS was consolidated with FDI during
fiscal 1997.
During the three months ended January 31, 1998 and 1997, the Company had losses
from operations of approximately $508,000 and $5,194,000, respectively. During
the three months ended January 31, 1997, the Company recognized an impairment
loss related to the closure of Parkside of approximately $4,954,000.
During the three months ended January 31, 1998 and 1997, the Company realized
net revenues of approximately $14,265,000 and $17,635,000, respectively.
During the three months ended January 31, 1998 and 1997, Radnet realized net
revenues of approximately $11,795,000 and $10,725,000, respectively. New centers
added after January 31, 1997, including University Imaging, Woodward Park and
Oxnard Imaging, generated net revenues of approximately $850,000 during the
first quarter of 1998. In addition, during the three months ended January 31,
1998, Vacaville's net revenue increased approximately 63% with the addition of a
CT, and the centers at Northridge, Westchester, Santa Rosa, Lancaster and Orange
collectively increased their net revenues approximately 22% from the previous
year's quarter. On the other hand, Santa Clarita's net revenues decreased
approximately 15% primarily due to a loss of certain contracts and La Habra's
net revenues decreased approximately 58% with the partnership dissolution and
the related loss of contracted CT business. Subsequent to the quarter's end, the
Company added MRI's at Stockton and Oxnard which increased their revenues
significantly.
12
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
- ------------------------------------------------------------------------------
Results of Operations [Continued]
During the three months ended January 31, 1998 and 1997, DIS realized net
revenues of approximately $2,400,000 and $5,300,000, respectively. Subsequent to
January 31, 1997, DIS sold four of its hospital-based MRI facilities and its
Ultrasound Division to Diagnostic Health Services, Inc. ["DHS"], closed Parkside
Radiology, closed West L.A. MRI Center, and sold Scripps Chula Vista MRI L.P.
["SCV"] to DHS. The combined net revenues of these sites for the three months
ended January 31, 1998 and 1997 was approximately $317,000 and $3,161,000,
respectively. For the three months ended January 31, 1998, SCV and Parkside
Radiology Women's Center generated net revenues of approximately $174,000 and
$143,000, respectively. MDI and Camarillo's net revenues for the three months
ended January 31, 1998 increased approximately 25% while the remaining sites
overall net revenues remained consistent or decreased slightly from the previous
quarter. In addition, during the three months ended January 31, 1998, DIS
recorded a contractual adjustment of approximately $225,000 on the historical
accounts receivable from its previously closed or sold sites.
During the three months ended January 31, 1998 and 1997, FDI generated net
revenues of approximately $-0- and $1,610,000, respectively. FDI was sold to
Preferred Health Management, Inc. ["PHM"] effective September 3, 1997. During
the three months ended January 31, 1998 and 1997, PHS generated net revenues of
$70,000 and $-0-, respectively, for billing fee income.
During the three months ended January 31, 1998 and 1997, the Company incurred
operating expenses of approximately $14,773,000 and $22,831,000, respectively.
For the three months ended January 31, 1998 and 1997, Radnet's operating
expenses were approximately $10,968,000 and $10,345,000, respectively, DIS's
operating expenses were approximately $3,055,000 and $8,927,000, respectively,
FDI's and RMIS's operating expenses were approximately $84,000 and $1,360,000,
respectively, and PHS's operating expenses were approximately $666,000 and
$2,199,000, respectively. The 1998 operating expense decrease is primarily
attributable to the sales of DIS's Ultrasound Division and MRI sites to DHS, the
sale of FDI to PHM, and the closure of Parkside and recognition of an impairment
loss of approximately $4,954,000 during the three months ended January 31, 1997.
During the three months ended January 31, 1998 and 1997, the Company's operating
expenses consisted of approximately $6,400,000 and $6,785,000, respectively, for
salaries and reading fees, approximately $-0- and $912,000, respectively, for
radiology site costs related to FDI, approximately $1,315,000 and $1,540,000,
respectively, for building and equipment rentals, approximately $4,455,000 and
$5,695,000, respectively, in general and administrative expenditures,
approximately $2,117,000 and $2,375,000, respectively, in depreciation and
amortization, approximately $486,000 and $570,000, respectively, for provisions
for bad debt, and approximately $-0- and $4,954,000 attributable to the
recognition of an impairment loss, pursuant to FASB 121, for the writedown of
assets related to the closure of Parkside.
During the three months ended January 31, 1998 and 1997, interest income was
approximately $105,000 and $53,000, respectively. Interest income for 1998
consisted primarily of imputed interest income on notes receivable due from PHM,
DHS and related parties. Interest income for 1997 consisted primarily of imputed
interest income on related party note receivables.
During the three months ended January 31, 1998 and 1997, interest expense was
approximately $2,225,000 and $2,660,000, respectively.
13
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
- ------------------------------------------------------------------------------
Results of Operations [Continued]
During the three months ended January 31, 1998 and 1997, the Company recognized
other income of approximately $132,000 and $135,000, respectively. During the
three months ended January 31, 1998, the Company realized a gain from the sale
of SCV to DHS of approximately $248,000 and an additional gain from the sale of
FDI to PHM [final post-closing adjustment] of approximately $88,000.
During the three months ended January 31, 1998, the Company realized an
extraordinary gain from early extinguishment of debt of approximately $590,000
from the repurchase and retirement of subordinated bond debentures and the
settlement of limited partner notes payable at a discount.
During the three months ended January 31, 1998, the Company adopted the
Accounting Standards Executive Committee's ["AcSEC"] Statement of Position
["SOP"] No. 98-5, "Reporting on the Costs of Start-up Activities." As a result
of this decision, in January 1998, the Company reduced historical net
organizational costs and capitalized fees by approximately $780,000.
During the three months ended January 31, 1998 and 1997, the Company had net
losses of approximately $2,438,000 and $7,809,000, respectively
Liquidity and Capital Resources
Cash increased for the three months ended January 31, 1998 and 1997 by
approximately $336,000 and $24,000, respectively.
Cash utilized for investing activities for the three months ended January 31,
1998 and 1997 was approximately $1,280,000 and $450,000, respectively. For the
three months ended January 31, 1998 and 1997, the Company acquired additional
DIS stock for approximately $488,000 and $67,000, respectively, and purchased
property and equipment of approximately $737,000 and $384,000, respectively. In
addition, during the three months ended January 31, 1998, the Company sold
medical equipment for $20,000, and loaned $75,000 to related parties.
Cash generated from financing activities for the three months ended January 31,
1998 was approximately $2,004,000. Cash utilized for financing activities for
the three months ended January 31, 1997 was approximately $980,000. During the
three months ended January 31, 1998 and 1997, the Company increased its cash
overdraft by approximately $581,000 and $615,000, respectively, made principal
payments on capital leases and notes payable of approximately $2,513,000 and
$1,815,000, respectively, received proceeds from borrowing under existing lines
of credit and refinancing arrangements of approximately $4,950,000 and $620,000,
respectively, and repurchased subordinated bond debentures for approximately
$1,095,000 and $170,000, respectively. In addition, during the three months
ended January 31, 1998 and 1997, the Company received $75,000 from its SCV joint
venture partner and $5,750 from the issuance of common stock, and distributed
approximately $230,000 to its joint venture partners, respectively.
At January 31, 1998, the Company had a working capital deficit of $14,079,982 as
compared to a working capital deficit of $12,027,033 at October 31, 1997, a
decrease of $2,052,949. The decrease from year-end is primarily attributable to
increased borrowings from the Company's existing lines of credit which are
classified as current liabilities on the Company's financial statements.
14
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
- ------------------------------------------------------------------------------
Liquidity and Capital Resources [Continued]
The Company's working capital needs are currently provided under two lines of
credit. Under one agreement, due December 31, 1998, the Company may borrow the
lesser of 75% to 80% of eligible accounts receivable, $10,000,000 or the prior
120-days' cash collections. Borrowings under this line are repayable together,
with interest, at an annual rate equal to the greater of (a) the bank's prime
rate plus 3%, or (b) 10%. The lender holds a first lien on substantially all of
Radnet's [Beverly Radiology's] assets to secure repayment under this line of
credit. The President and C.E.O. of PHS has personally guaranteed $3,000,000 of
the loans. In addition, the credit line is collateralized by a $5,000,000 life
insurance policy on the President and C.E.O. of PHS. At January 31, 1998,
approximately $9,070,000 was outstanding under this line.
Under a second line of credit, renewed on a month-to-month basis, the Company
may borrow the lesser of 75% of the eligible accounts receivable, $4,000,000 or
the prior 120-days' cash collections. Borrowings under this line are repayable
together with interest at an annual rate of the bank's prime rate plus 3-1/2%.
The credit line is collateralized by approximately 80% of the Tower division's
[Radnet Sub, Inc.] accounts receivable. As of January 31, 1998, approximately
$2,115,000 was outstanding under this line. Subsequent to the quarter's end,
this line of credit was renegotiated where the Company can now borrow the lesser
of 75% of the eligible accounts receivable, $5,000,000 or the prior 120-days'
cash collections. The President and C.E.O. of PHS has personally guaranteed
$1,000,000 of the loans.
The Company's future payments for debt and equipment under capital lease for the
next five years, assuming lines of credit are paid in the first year and not
renewed, will be approximately $29,800,000, $15,925,000, $15,950,000,
$13,125,000 and $11,500,000, respectively. Interest expense [excluding line of
credit and bond debenture interest] for the next five years, included in the
above payments, will be approximately $5,575,000, $4,175,000, $3,000,000,
$1,775,000 and $875,000, respectively. In addition, the Company has
non-cancelable operating leases for use of its facilities and certain medical
equipment which will average approximately $3,300,000 in annual payments over
the next five years.
The Company has approximately $250,000 on its books for accrued restructuring
costs associated with the buyout and renegotiation of employment contracts which
will be fully utilized by fiscal year-end 1998.
At three of the Company's Tower locations [120 East, 444 San Vicente and 1
West/Womens], the Company's leases expire at various times beginning in January
1999. Due to this, the Company has entered into a new lease agreement for nearby
space in Beverly Hills ["Wilshire"] and will consolidate the assets and business
of these three Tower locations to the new space during fiscal 1999. The Company
cannot predict whether the move will negatively impact the volume of business
previously obtained from these three centers, but the new site will reduce
respective average building rental disbursements by approximately $1,015,000 per
year [including note payment disbursements assumed upon the acquisition of Tower
in October 1994]. For the three months ended January 31, 1998, the combined net
revenue for these three sites was approximately $3,050,000.
15
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
PART II - OTHER INFORMATION
- ------------------------------------------------------------------------------
Item 5: Other Information
In February 1998, effective December 31, 1997, the Company dissolved its
partnership between La Habra Imaging Group II and Friendly Hills Healthcare
Network, Inc. ["Friendly Hills"]. Upon the dissolution, the Company wrote-off
approximately $270,000 of Friendly Hills accounts receivable, approximately
$365,000 in net property, approximately $130,000 of accrued expenses and
approximately $435,000 in minority interest. The Company recorded a short-term
receivable of approximately $23,000 on the dissolution and continues to operate
the now wholly-owned La Habra center. As part of the dissolution, Friendly Hills
acquired the modular building utilized by the center. The Company entered into a
five-year building lease with Friendly Hills for the building with an initial
base rent of $3,034 per month.
In March 1998, effective January 1, 1998, the Company's Diagnostic Imaging
Services, Inc. subsidiary sold its partnership interest in Scripps Chula Vista
MRI L.P. ["SCV"] to Diagnostic Health Services, Inc. ["DHS"] for 127,250 shares
of DHS stock. On May 15, 1998, the Company sold the shares for which it received
approximately $1,230,000.
16
<PAGE>
PRIMEDEX HEALTH SYSTEMS, INC. AND AFFILIATES
SIGNATURES
- ------------------------------------------------------------------------------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Primedex Health Systems, Inc. and Affiliates
(Registrant)
May 19, 1998 By: /s/ Howard G. Berger
------------------------
Howard G. Berger, M.D., President, Principal
Executive Officer, Financial Officer and Director
<PAGE>
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated balance sheet and the consolidated statement of operations and is
qualified in its entirety by reference to such statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-mos
<FISCAL-YEAR-END> Oct-31-1998
<PERIOD-END> Jan-31-1998
<CASH> 465,735
<SECURITIES> 1,431,563
<RECEIVABLES> 17,082,607
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 21,782,060
<PP&E> 32,200,444
<DEPRECIATION> 0
<TOTAL-ASSETS> 83,733,094
<CURRENT-LIABILITIES> 35,862,042
<BONDS> 0
0
0
<COMMON> 407,572
<OTHER-SE> (27,744,131)
<TOTAL-LIABILITY-AND-EQUITY> 83,733,094
<SALES> 0
<TOTAL-REVENUES> 14,264,936
<CGS> 0
<TOTAL-COSTS> 14,772,505
<OTHER-EXPENSES> (573,794)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 2,226,597
<INCOME-PRETAX> (2,247,533)
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,247,533)
<DISCONTINUED> 0
<EXTRAORDINARY> 589,122
<CHANGES> (779,294)
<NET-INCOME> (2,437,705)
<EPS-PRIMARY> (0.06)
<EPS-DILUTED> (0.06)
</TABLE>
